Nike Inc. is asking the International Trade Commission in Washington to block imports of Adidas AG Primeknit shoes for infringing its patented invention for a knitted fabric that reduces waste while maintaining performance.
The patents are for Nike’s FlyKnit technology, which creates a sock-like fit in the upper part of the shoe by using the use of specialized yarn from recycled and reclaimed materials.
Nike said it developed the technology by spending over $100 million for a decade of research and it was the first major technological innovation in footwear uppers in decades.
The shoes that Nike hopes to ban include Adidas by Stella McCartney Ultraboost, Pharrell Williams Superstar Primeknit Shoes, and Terrex Free Hiker hiking shoes.
Nike also made similar allegations in its patent-infringement suit in federal court in Oregon.
After FlyKnit was introduced before the 2012 London Olympics, it has been adopted by hoops icon LeBron James, soccer superstar Cristiano Ronaldo, and world record marathoner Eliud Kipchoge.
Nike said that Adidas has forgone independent innovation while spending the past decade unsuccessfully challenging several of its FlyKnit technology patents while using Nike’s patented technology without permission.
According to Nike, it was forced to sue Adidas for its unauthorized use to defend its investments.
Meanwhile, Adidas said it would defend itself against the allegations..
Adidas spokeswoman Mandy Nieber claims that its Primeknit technology resulted from years of dedicated research.


Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Australia’s December Trade Surplus Expands but Falls Short of Expectations
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Instagram Outage Disrupts Thousands of U.S. Users
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Google Halts UK YouTube TV Measurement Service After Legal Action
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Supreme Court Tests Federal Reserve Independence Amid Trump’s Bid to Fire Lisa Cook
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



